is dulaglutide a glp 1 GLP-1 receptor agonists and beyond. Part 1: benefits in type 2 diabetes Chemical structures of GLP-1 RAs

The framework prioritised semaglutide and tirzepatide as first-line treatments, based on evidence of 15% weight loss and benefits in complications such as cardiovascular disease and sleep apnoea

Its dual mechanism as a GLP-1 receptor agonist provides powerful effects on both glycemic control and body weight regulation, with efficacy that exceeds previous pharmacological approaches

GLP-1 constipation relief strategies that work

Expert articles on GLP-1 weight loss, cellular optimization, women's health, and men's health written by REMEVi's medical team in English and Spanish.

However, further research is needed to fully understand how these therapies exert their effect on body weight and in the last section we cover open questions about the potential mechanisms of multiagonist drugs, and the understanding of how gutbrain communication can be leveraged to achieve sustained body weight loss without adverse effects.